Belbuca and Dalfampridine drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Belbuca (buprenorphine hydrochloride) and Dalfampridine (dalfampridine). Common drug interactions include abdominal pain upper among females.
The phase IV clinical study analyzes what interactions people have when they take Belbuca and Dalfampridine. It is created by eHealthMe based on reports of 6 people who take the same drugs from the FDA, and is updated regularly.
What is Belbuca?
Belbuca has active ingredients of buprenorphine hydrochloride. eHealthMe is studying from 3,022 Belbuca users. Check the latest studies of Belbuca.
What is Dalfampridine?
Dalfampridine has active ingredients of dalfampridine. eHealthMe is studying from 9,658 Dalfampridine users. Check the latest studies of Dalfampridine.
6 people who take Belbuca and Dalfampridine together, and have interactions are studied.
What are the common drug interactions of Belbuca and Dalfampridine, by gender? *:
female:
- Abdominal pain upper
- Back pain
- Liver disorder (liver diseases)
- Multiple sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath)
- Muscle spasms (muscle contraction)
- Pain in extremity
- Discomfort
- Fall
- Fatigue (feeling of tiredness)
- Gait disturbance
male:
n/a
What are the common drug interactions of Belbuca and Dalfampridine, by age (0-1 to 60+)? *:
0-1:
n/a
2-9:
n/a
10-19:
n/a
20-29:
n/a
30-39:
n/a
40-49:
n/a
50-59:
- Abdominal pain upper
- Back pain
- Discomfort
- Dizziness
- Drug ineffective
- Dyspepsia (indigestion)
- Fall
- Fatigue (feeling of tiredness)
- Headache (pain in head)
- Intervertebral disc degeneration (spinal disc degeneration)
60+:
- Abdominal pain upper
- Asthenia (weakness)
- Gait disturbance
- Multiple sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath)
- Muscle contractions involuntary (uncontrolled muscle contraction)
- Muscle spasms (muscle contraction)
- Pain in extremity
- Back pain
- Balance disorder
- Dizziness
* Approximation only. Some reports may have incomplete information.
Do you take Belbuca and Dalfampridine?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
- Belbuca (3,022 reports)
- Dalfampridine (9,658 reports)
Browse all drug interactions of Belbuca and Dalfampridine:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Belbuca:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Dalfampridine:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Belbuca and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Dalfampridine and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zHow the study uses the data?
The study uses data from the FDA. It is based on buprenorphine hydrochloride and dalfampridine (the active ingredients of Belbuca and Dalfampridine, respectively), and Belbuca and Dalfampridine (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Tramadol cause Bipolar Disorder? - now
- Could Tramadol cause Bi-Polar? - a second ago
- Drug interactions of Vitamin B12 and Plendil - a second ago
- Could Bortezomib cause Nephrotic Syndrome? - 9 seconds ago
- Could Tiotropium Bromide cause Dyspnea Exacerbated? - 10 seconds ago
- Could Isosorbide Mononitrate cause Agranulocytosis? - 12 seconds ago
- Drug interactions of Vasotec and Januvia - 16 seconds ago
- Could Aloxi cause Gait Disturbance? - 17 seconds ago
- Drug interactions of Cipro and Motrin - 18 seconds ago
- Could Quetiapine Fumarate cause Acute Upper Airway Obstruction? - 20 seconds ago